connect with us

Bookmark and Share
Print Friendly and PDF
Learn more about the DRI's progress toward a cure.
Under the Microscope enewsletter banner
                                                                    DONATE NOW

July 24, 2014 

Researchers Develop Unique Cell Encapsulation Method 
DRI's Dr. Alice Tomei and her team developed the conformal coating islet cell encapsulation process.

Dr. Alice Tomei and her team have developed a novel process for conformal coating of islets that was designed to address the limitations of traditional cell encapsulation methods. The results of the team's study were recently published in Proceedings of the National Academy of Sciences
Read more 

The Iacocca Foundation Awards Grants for DRI's Innovative Research 
Iacocca Foundation

The ability to stop the immune system from attacking insulin-producing islet cells is critical for restoring natural insulin production and reaching a biological cure. Thanks to recent grant awards from The Iacocca Foundation, two of the DRI scientists who are making important inroads in this area will be able to continue their innovative research. 
Read more

Pilot Clinical Trial will Test a New Site in the Body for DRI BioHub Platform
The DRI has launched a pilot clinical trial to test the omentum as a possible transplant site for a BioHub.

The DRI has received FDA approval to begin a Phase I/II clinical trial that will test the omentum, the inside lining of the abdomen, as a potential site in the body for a DRI BioHub. Researchers will transplant islet cells within a "biodegradable scaffold," one of the platforms considered for a BioHub. Read more
Watch DRI tv for more on the pilot trial

Norma Sue Kenyon, Ph.D., Appointed to NIH Council of Councils
DRI's Norma Sue Kenyon, Ph.D., appointed to NIH Council on Councils

Dr. Norma Sue Kenyon, Martin Kleiman Professor and senior scientist at the DRI, was among nine individuals recently appointed to the National Institutes of Health (NIH) Council of Councils, which advises on policies and activities and makes recommendations on important areas of emerging scientific opportunities, among other decisions.
Read more

Under the Microscope with...Giacomo Lanzoni, Ph.D.
DRI's Dr. Giacomo Lanzoni

DRI researchers are developing and testing a special class of manufactured molecules, called aptamers, that can “hone in” on specific cell markers, including those that are unique to insulin-producing beta cells. Dr. Giacomo Lanzoni explains how this new "tool" presents a novel way to target beta cells within the body.
Read more
 

Please Support the DRI's Cure-Focused Research!   

Diabetes Research Institute Foundation 
National Office  |  200 S. Park Road, Hollywood, FL 33021 
Phone: 800.321.3437  |  Email: info@drif.org
Privacy Policy Visit Our Website  |  Unsubscribe
 

Diabetes Research Institute Foundation
200 S. Park Road, Suite 100
Hollywood, FL 33021
[P]   (954) 964-4040
[TF] (800) 321-3437
[F]   (954) 964-7036

Join Us on FacebookWatch us on YouTubeFollow Us on Twitter

BBB Wise Giving Alliance Accredited Charity  The Diabetes Research Institute Foundation is a Gold Level Participant on the GuideStar Exchange.  The Blue Circle - the global symbol for diabetes

Home | LoginDRInsider Sign Up | Site MapSite Search Contact UsDirectionsRecommended LinksPrivacy and Terms of Use | Mission Statements

© 2016 Diabetes Research Institute Foundation - National Office: 200 S. Park Road, Suite 100, Hollywood, FL 33021 - (954) 964-4040

Miller School of Medicine